300 results on '"Thibaut, Hendrik Jan"'
Search Results
2. YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge
3. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
4. Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models
5. Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
6. Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
7. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2–infected hamsters, whereas hydroxychloroquine lacks activity
8. Use of Micro-Computed Tomography to Visualize and Quantify COVID-19 Vaccine Efficiency in Free-Breathing Hamsters
9. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
10. Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine.
11. Animal models for COVID-19
12. Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
13. Role of enhanced receptor engagement in the evolution of a pandemic acute hemorrhagic conjunctivitis virus
14. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
15. The life cycle of non-polio enteroviruses and how to target it
16. Reduced hepatic bile acid uptake and blocked hepatitis B viral infection after oral administration of novel small molecule inhibitors of the sodium taurocholate co-transporting polypeptide (NTCP)
17. Validation of a Reporter Cell Line for Flavivirus Inhibition Assays
18. Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
19. Enterovirus D68 receptor requirements unveiled by haploid genetics
20. Bypassing pan-enterovirus host factor PLA2G16
21. FLUIDOT: A Modular Microfluidic Platform for Single‐Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining (Small Methods 3/2023)
22. Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery
23. Single-dose YF17D-vectored Ebola vaccine candidate protects mice against both lethal surrogate Ebola and yellow fever virus challenge
24. Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques
25. MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
26. PLA2G16 represents a switch between entry and clearance of Picornaviridae
27. Efficient synthesis and anti-enteroviral activity of 9-arylpurines
28. A High-Throughput Yellow Fever Neutralization Assay
29. High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium
30. Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
31. MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
32. Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings
33. Real-world monitoring of BNT162b2 vaccine-induced SARS-CoV-2 B and T cell immunity in naive healthcare workers: a prospective single center study
34. Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron)
35. A high-throughput neutralization assay for yellow fever serodiagnostics
36. An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
37. Updated vaccine protects from infection with SARS-CoV-2 variants, prevents transmission and is immunogenic against Omicron in hamsters
38. Publisher Correction: The life cycle of non-polio enteroviruses and how to target it
39. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence
40. The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis
41. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1
42. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
43. Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents
44. Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice
45. enAsCas12a Enables CRISPR-Directed Evolution to Screen for Functional Drug Resistance Mutations in Sequences Inaccessible to SpCas9
46. FRI-231 - Reduced hepatic bile acid uptake and blocked hepatitis B viral infection after oral administration of novel small molecule inhibitors of the sodium taurocholate co-transporting polypeptide (NTCP)
47. Combating enterovirus replication: State-of-the-art on antiviral research
48. Towards the design of combination therapy for the treatment of enterovirus infections
49. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
50. A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.